Quick Summary: Crystal Mackall, MD, Stanford University, Stanford, CA, explains the rationale and the results from a Phase I trial investigating the ... At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, ...
Cd19 Targeted Car T Cell 29577 -
Crystal Mackall, MD, Stanford University, Stanford, CA, explains the rationale and the results from a Phase I trial investigating the ... At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, ... Park, MD, attending physician, Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses a trial presented at ...
Important details found
- Crystal Mackall, MD, Stanford University, Stanford, CA, explains the rationale and the results from a Phase I trial investigating the ...
- At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, ...
- Park, MD, attending physician, Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses a trial presented at ...
- Sara Ghorashian, PhD, MD, FRCP, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, shares some ...
- Johanna Richter, Transplant Physician, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, comments on the ...
Why this topic is useful
This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.
Frequently Asked Questions
Why are related topics included?
Related topics help readers compare nearby references and understand the broader subject.
What is this page about?
This page summarizes Cd19 Targeted Car T Cell 29577 and connects it with related entries, references, and supporting context.
Is the information always complete?
Not always. Some topics may need verification from official or primary sources.
